DD128610A5 - Verfahren zur herstellung substituierter phenoxypropanolamin-derivate - Google Patents
Verfahren zur herstellung substituierter phenoxypropanolamin-derivateInfo
- Publication number
- DD128610A5 DD128610A5 DD7700197617A DD19761777A DD128610A5 DD 128610 A5 DD128610 A5 DD 128610A5 DD 7700197617 A DD7700197617 A DD 7700197617A DD 19761777 A DD19761777 A DD 19761777A DD 128610 A5 DD128610 A5 DD 128610A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- producing substituted
- phenoxypropanolamine
- derivatives
- phenoxypropanolamine derivatives
- substituted
- Prior art date
Links
- UJUKHOATWVVDER-UHFFFAOYSA-N 1-amino-1-phenoxypropan-1-ol Chemical class CCC(N)(O)OC1=CC=CC=C1 UJUKHOATWVVDER-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU76GO00001331A HU172137B (hu) | 1976-03-02 | 1976-03-02 | Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD128610A5 true DD128610A5 (de) | 1977-11-30 |
Family
ID=10996805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD7700197617A DD128610A5 (de) | 1976-03-02 | 1977-03-01 | Verfahren zur herstellung substituierter phenoxypropanolamin-derivate |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4310549A (xx) |
| JP (1) | JPS5923299B2 (xx) |
| AT (1) | AT348507B (xx) |
| AU (1) | AU508766B2 (xx) |
| BE (1) | BE851938A (xx) |
| CA (1) | CA1091254A (xx) |
| CH (1) | CH627732A5 (xx) |
| CS (1) | CS190340B2 (xx) |
| DD (1) | DD128610A5 (xx) |
| DE (1) | DE2709109C3 (xx) |
| DK (1) | DK143554C (xx) |
| FI (1) | FI65231C (xx) |
| FR (1) | FR2342956A1 (xx) |
| GB (1) | GB1573191A (xx) |
| HU (1) | HU172137B (xx) |
| IL (1) | IL51574A (xx) |
| IN (1) | IN144243B (xx) |
| KE (1) | KE3340A (xx) |
| MY (1) | MY8500104A (xx) |
| NL (1) | NL7702170A (xx) |
| NO (1) | NO141989C (xx) |
| PL (1) | PL103734B1 (xx) |
| SE (1) | SE440647B (xx) |
| SU (1) | SU648080A3 (xx) |
| YU (1) | YU40813B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004106299A2 (en) * | 2003-05-30 | 2004-12-09 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| KR101329112B1 (ko) * | 2005-11-08 | 2013-11-14 | 랜박시 래보러터리스 리미티드 | (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법 |
| WO2008020314A2 (en) * | 2006-03-14 | 2008-02-21 | Ranbaxy Laboratories Limited | Statin stabilizing dosage formulations |
| MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH569692A5 (xx) | 1971-03-17 | 1975-11-28 | Richter Gedeon Vegyeszet | |
| US4067904A (en) * | 1975-12-19 | 1978-01-10 | Mead Johnson & Company | Alkylsulfonylphenoxypropanolamine derivatives |
-
1976
- 1976-03-02 HU HU76GO00001331A patent/HU172137B/hu not_active IP Right Cessation
-
1977
- 1977-02-25 CH CH235877A patent/CH627732A5/de unknown
- 1977-02-28 AT AT134177A patent/AT348507B/de not_active IP Right Cessation
- 1977-03-01 CS CS771363A patent/CS190340B2/cs unknown
- 1977-03-01 SU SU772457128A patent/SU648080A3/ru active
- 1977-03-01 FR FR7705898A patent/FR2342956A1/fr active Granted
- 1977-03-01 CA CA272,912A patent/CA1091254A/en not_active Expired
- 1977-03-01 DD DD7700197617A patent/DD128610A5/xx unknown
- 1977-03-01 IL IL51574A patent/IL51574A/xx unknown
- 1977-03-01 YU YU549/77A patent/YU40813B/xx unknown
- 1977-03-01 NO NO770688A patent/NO141989C/no unknown
- 1977-03-01 GB GB8593/77A patent/GB1573191A/en not_active Expired
- 1977-03-01 BE BE1007979A patent/BE851938A/xx not_active IP Right Cessation
- 1977-03-01 DK DK88577A patent/DK143554C/da not_active IP Right Cessation
- 1977-03-01 NL NL7702170A patent/NL7702170A/xx not_active Application Discontinuation
- 1977-03-01 IN IN292/CAL/77A patent/IN144243B/en unknown
- 1977-03-01 PL PL1977196357A patent/PL103734B1/pl unknown
- 1977-03-01 FI FI770651A patent/FI65231C/fi not_active IP Right Cessation
- 1977-03-01 SE SE7702251A patent/SE440647B/xx not_active IP Right Cessation
- 1977-03-01 AU AU22795/77A patent/AU508766B2/en not_active Expired
- 1977-03-02 DE DE2709109A patent/DE2709109C3/de not_active Expired
- 1977-03-02 JP JP52021640A patent/JPS5923299B2/ja not_active Expired
-
1979
- 1979-09-04 US US06/072,295 patent/US4310549A/en not_active Expired - Lifetime
-
1983
- 1983-10-24 KE KE3340A patent/KE3340A/xx unknown
-
1985
- 1985-12-30 MY MY104/85A patent/MY8500104A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT351164B (de) | Verfahren zur herstellung von neuen cephalos- porinderivaten | |
| AT362782B (de) | Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten | |
| AT363196B (de) | Verfahren zur herstellung von androstan-17-on-derivaten | |
| DD127900A5 (de) | Verfahren zur herstellung von mercaptoazetidin-derivaten | |
| AT362781B (de) | Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten | |
| AT352701B (de) | Verfahren zur herstellung von m-phenoxybenzal- dehyd | |
| DD131856A6 (de) | Verfahren zur herstellung substituierter purinverbindungen | |
| ATA145077A (de) | Verfahren zur herstellung von neuen ergolen- -derivaten | |
| DD131021A5 (de) | Verfahren zur herstellung substituierter aminochinazolinderivate | |
| AT356129B (de) | Verfahren zur herstellung von substituierten 1-carbamoyl-2-cyanaziridinen | |
| AT355725B (de) | Verfahren zur herstellung stabiler loesungen | |
| AT361639B (de) | Verfahren zur herstellung von 5-androsten-17- -on-derivaten | |
| DD128610A5 (de) | Verfahren zur herstellung substituierter phenoxypropanolamin-derivate | |
| ATA736576A (de) | Verfahren zur herstellung neuer indolderivate | |
| AT352910B (de) | Verfahren zur herstellung von beta-mehtyl- digoxin | |
| DD128611A5 (de) | Verfahren zur herstellung substituierter purinverbindungen | |
| AT363625B (de) | Verfahren zur herstellung von 21-hydroxy-20methyl-pregnan-derivaten | |
| AT366695B (de) | Verfahren zur herstellung von 3-brommethyl-3cephemsulfoxydderivaten | |
| ATA966976A (de) | Verfahren zur herstellung von 2-aminoindanderivaten | |
| AT368500B (de) | Verfahren zur herstellung von ergolin-derivaten | |
| DD130659A5 (de) | Verfahren zur herstellung von oxothiaverbindungen | |
| DD128959A1 (de) | Verfahren zur herstellung breiter textiler verbundstoffe | |
| AT362369B (de) | Verfahren zur herstellung von furocumarin- derivaten | |
| AT353790B (de) | Verfahren zur herstellung von indolderivaten | |
| AT382148B (de) | Verfahren zur herstellung von chinazolinonderivaten |